UnitedHealth Group shares steady, analysts keep focus on Optum
Published on 06/24/2026 at 07:05 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
By Anna Wagner, Analysts & Consensus desk. Reviewed prior to publication on 2026-06-24, 07:04.
UnitedHealth Group (US91324P1021) sits in the S&P 500 as traders on Wall Street digest the latest price data and analyst commentary. Reuters reports that the company raised its full-year 2026 adjusted earnings outlook after first-quarter results, with adjusted EPS of $7.23 versus a $6.57 consensus estimate.
What Reuters reported
Reuters said UnitedHealth lifted its full-year adjusted earnings guidance to greater than $18.25 per share after revenue reached $111.72 billion in the first quarter. The report also cited $6.28 billion in net income and a medical benefit ratio of 83.9%. Reuters report on the first-quarter update
That keeps the stock tied to a clear earnings and guidance story on Wall Street. The same report noted that Optum revenue declined to $24.1 billion, while Medicare Advantage enrollment fell by 965,000.
Analysts stay active
On the analyst side, Investing.com summarized Bernstein SocGen as reiterating its UnitedHealth view on the Optum outlook, one of several dated research notes circulating in the market. The coverage focus stays on the company's health services platform and the pace of margin repair. FinanzNachrichten market feed on UnitedHealth
UnitedHealth shares also trade as a large S&P 500 healthcare name, so every guidance update feeds directly into sector comparisons. That makes the company a regular reference point against peers such as CVS Health and Elevance Health.
All news and analysis on UnitedHealth Group shares
The company remains one of the most closely watched healthcare names in the S&P 500, with investors tracking earnings, Optum, and Medicare Advantage.
How UnitedHealth makes money
UnitedHealth's core business spans UnitedHealthcare insurance coverage and Optum health services, including pharmacy benefits and care delivery. OptumRx and broader care management remain central to the company's earnings mix.
Where the shares trade
The UnitedHealth Group shares (US91324P1021) trade on 2026-06-24, 07:04 on the NYSE at $409.25.
UnitedHealth Group at a glance
- Company: UnitedHealth Group Incorporated
- ISIN: US91324P1021
- Ticker: UNH
- Trading venue: NYSE
- Price (as of 2026-06-24, 07:04): $409.25 USD
- Sector / industry: Health Care / Managed Health Care
- Index membership: S&P 500
This article is for information only and does not constitute investment advice.
Disclaimer regarding our articles: No investment advice, no buy or sell recommendation. Information on prices, companies, and markets is provided without guarantee; changes are possible at any time. Stock market transactions can lead to substantial losses. Our articles are created and reviewed in whole or in part automatically with the support of AI.
